biotechnology - Page 3 of 4 - Providence Business News

RUBIUS THERAPEUTICS reported a $32.6 million loss in the first quarter of 2019.

Rubius Therapeutics reports $32.6M loss in Q1

Entrepreneurship 05/15/2019

SMITHFIELD – Rubius Therapeutics Inc. reported a net loss of $32.6 million in the first quarter of 2019, or 42 cents per diluted share,...

A SEALED court filing related to Amgen’s Mvasi and Genentech’s Avastin, both chemotherapy and targeted therapy drugs, was filed in U.S. District Court in Delaware Friday. / BLOOMBERG NEWS FILE PHOTO

Amgen and Genentech ‘patent dance’ continues in sealed filings

Health Services 04/01/2019

PROVIDENCE – A sealed lawsuit was filed in Delaware District Court Monday against Immunex Rhode Island Corp. and Amgen Inc. by Genentech Inc. and...

IlluminOss breakthrough lands it in the biotech marketplace

Editorial and Op-Ed 03/01/2019

For years regional business and governmental leaders have been touting the potential here for breakthrough life sciences and biotechnology ventures. This week, one of...

THOMAS SEEWOESTER has replaced Tia Bush as Amgen's vice president of site operations for its Rhode Island and Woburn, Mass., facilities. Bush has taken on the role of senior vice president of quality at the company's headquarters in Thousand Oaks, Calif. / COURTESY AMGEN INC.

Seewoester replaces Bush as Amgen VP of site operations for R.I.,...

People 11/26/2018

PROVIDENCE – Tia Bush has moved on from her role as Amgen Inc.’s vice president of site operations, Rhode Island and Woburn, Mass., to...

A RENDERING of the newly announced Ortho Rhode Island facility in Warwick. / COURTESY CARPIONATO GROUP

Carpionato Group unveils plans for Ortho Rhode Island office and surgical...

Health Services 08/22/2018

WARWICK – The Carpionato Group has the final approval of the city Planning Board to build a bio-medical hub – a 100,000-square-foot, three-story medical...

Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield

Entrepreneurship 07/25/2018

SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to...

the prop: This pair of hand-decorated pumps with New England Patriots logos and red sequin trim took Tracy Schorner about three hours to make. She’s worn them to work during the playoffs and when she and friends watch a game together. / PBN PHOTO/MIKE SKORSKI

Tracy Schorner, 37

Capital Goods 07/20/2018

SENIOR MANAGER, MANUFACTURING – AMGEN RHODE ISLAND Where do you see yourself professionally in 20 years? Hopefully doing something impactful, rewarding and challenging, though part...

BBJ: Rubius Therapeutics raises $241M in IPO, highest for biotech company...

Entrepreneurship 07/18/2018

PROVIDENCE – Cambridge, Mass.-based Rubius Therapeutics Inc. raised $241 million in its initial public offering Wednesday, the highest for a biotechnology company in Massachusetts...

THE R.I. COMMERCE CORP. board of directors will consider $399,330 in Innovation Vouchers and $225,000 in Network Matching Grants. Above, Jesse Saglio, president of Commerce RI. / PBN FILE PHOTO/MICHAEL SALERNO

Commerce RI board approves $399K in innovation vouchers

Entrepreneurship 06/28/2018

PROVIDENCE – The R.I. Commerce Corp. met Thursday afternoon and approved Innovation Vouchers for eight companies and Network Matching Grants for two companies. Commerce RI...

Amgen’s focus on its employees’ future a workplace plus

Capital Goods 06/15/2018

BEST PLACES TO WORK 2018 1. ENTERPRISE | Amgen Rhode Island Employees in R.I.: 640 Tia Bush, vice president of site operations The 640 employees at West Greenwich...

1 234 Page 3 of 4

- Featured Event -

Tag: biotechnology

Latest News

SUBSCRIBE TO

SIGN UP FOR

FOLLOW US

MOST POPULAR

OUR MISSION

ABOUT PBN